A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis

NCT07709910 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Participants With Obesity and Knee Osteoarthritis

Interventions

DRUG: Ribupatide Injection
DRUG: Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.